Three‐Year Results of Tapering Tumor Necrosis Factor Inhibitor to Withdrawal Compared to Stable Tumor Necrosis Factor Inhibitor Among Patients With Rheumatoid Arthritis in Sustained Remission: A Multicenter Randomized Trial

Journal:

Arthritis & Rheumatology

Published:

2025-06-26

DOI:

10.1002/art.43199

Affiliations:

13

Authors:

21

Go to article

Institutions	Authors	Share
Center for treatment of Rheumatology and Musculoskeletal Diseases (REMEDY), Norway	11.000000 11.000000	0.52
Oslo University Hospital (OUS), Norway	1.000000	0.05
Vestre Viken Hospital Trust, Norway	1.000000	0.05
Haukeland University Hospital, Norway	1.000000	0.05
Helse Møre og Romsdal Hospital Trust, Norway	1.000000	0.05
Østfold Hospital, Norway	1.000000	0.05
University Hospital of North Norway (UNN), Norway	1.000000	0.05
Rheumatic Hospital Lillehammer, Norway	1.000000	0.05
Martina Hansens Hospital, Norway	1.000000	0.05
Helgelandssykehuset, Norway	1.000000	0.05
Brigham and Women's Hospital (BWH), United States of America (USA)	1.000000	0.05

Interested in Clinical Sciences?